Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Gisli Einarsson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Changes in biofilm-tolerance of Pseudomonas aeruginosa to tobramycin following treatment with tobramycin inhalation powder (TIP)
McCleave, R., Einarsson, G., Loebinger, M., Chalmers, J., Elborn, S. J., Haworth, C., Tunney, M. & Sherrard, L., 09 Jun 2023, In: Journal of Cystic Fibrosis. 22, p. S61-S62 2 p., EPS9.04 .Research output: Contribution to journal › Meeting abstract › peer-review
-
Early-life dysbiosis and Th17 asthma: never is better than late
Linden, D. A. & Einarsson, G. G., 15 Feb 2023, (Early online date) In: American Journal of Respiratory Cell and Molecular Biology.Research output: Contribution to journal › Article › peer-review
-
EPS9.06 Development of levofloxacin resistance in clinical Pseudomonas aeruginosa isolates from people with cystic fibrosis in an in vitro variable exposure model
Sloan, C. M., Sherrard, L. J., Einarsson, G. G., Tunney, M. M. & Downey, D. G., 01 Jun 2023, In: Journal of Cystic Fibrosis. 22 , Supplement 2, 1 p., S62.Research output: Contribution to journal › Meeting abstract › peer-review
-
P228 In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic fibrosis
Sloan, C. M., Sherrard, L. J., Einarsson, G. G., Hoffman, L. R., Tunney, M. M. & Downey, D. G., 01 Jun 2023, In: Journal of Cystic Fibrosis. 22, Supplement 2, S135.Research output: Contribution to journal › Meeting abstract › peer-review
-
P253 Optimisation of inhaled antibiotic prescribing for Pseudomonas aeruginosa infections in people with cystic fibrosis: Further insights from Principal Investigators of the ECFS Clinical Trials Network
Sloan, C. M., Sherrard, L. J., Einarsson, G. G., Dupont, L. J., van Koningsbruggen-Rietschel, S., Simmonds, N. J. & Downey, D. G., 09 Jun 2023, In: Journal of Cystic Fibrosis. 22 , Supplement 2, S143.Research output: Contribution to journal › Meeting abstract › peer-review
Open Access
Activities
- 3 Oral presentation
-
Multi-Omics Approaches for Managing Treatment in Cystic Fibrosis
Gisli Einarsson (Invited speaker)
10 Jun 2021Activity: Talk or presentation types › Oral presentation
File -
Lung/gut microbiome: role in respiratory infections
Gisli Einarsson (Keynote speaker)
07 Jun 2021Activity: Talk or presentation types › Oral presentation
File -
Effect of treatment with the TOBI Podhaler® on the airway microbiota in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study
Gisli Einarsson (Speaker)
16 Dec 2020 → 19 Dec 2020Activity: Talk or presentation types › Oral presentation